Anam Rizvi, MD
Gastroenterology · New York, NYNPI 1043746779
Payments from drug & device makers
Across 62 payments — averaging $525.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$30K
- Ovesco Endoscopy USA, Inc.$1K
- Fujifilm Healthcare Americas Corporation$529
- Conmed Corporation$251
- Intra-sana Laboratories$150
- Endogastric Solutions, Inc$140
- plus $109 from 4 others
What the payments were for
- Grants$25,00077%
- Travel & lodging$3,81012%
- Food & beverage$3,78412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 48 | $30,131 |
| Ovesco Endoscopy USA, Inc. | 1 | $1,284 |
| Fujifilm Healthcare Americas Corporation | 4 | $529 |
| Conmed Corporation | 3 | $251 |
| Intra-sana Laboratories | 1 | $150 |
| Endogastric Solutions, Inc | 1 | $140 |
| Novo Nordisk | 1 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Cook Medical LLC | 1 | $21 |
| Olympus America Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$25,000
- Resolution 360 Clip$708
- FUJIFILM$369
- APOLLO ESG System$304
- CONMED BILIARY$216
- Reltone 200 Mg$150
- GLYCATE$150
- Reltone 400 Mg$150
- BILIARY STENT INTRODUCER$146
- ESOPHYX$140
How this compares
$32,594 in reported general payments places this provider in the 85th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in New York
- David HudesmanNew York$3.6M
- Ellen ScherlNew York$2.9M
- Bruce SandsNew York$2.8M
- Arun SwaminathNew York$2.7M
- Sonal KumarNew York$2.3M
- David Carr LockeNew York$2.1M
- Arthur KornbluthNew York$1.9M
- Ira JacobsonNew York$1.8M
- James MarionNew York$1.7M
- Jean Frederick ColombelNew York$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.